Publications by authors named "Tracy Kemp"

Claim this Profile
S
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.
Alexander Rumyantsev, Lixia Wang, Shixia Wang, Tracy Kemp, Alana Wriggins

EClinicalMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.
Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, Wen-Jiun Peng, Yea-Huei Shen, Tracy Kemp

J Clin Invest· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.
D Gray Heppner, Tracy L Kemp, Brian K Martin, William J Ramsey, Richard Nichols

Lancet Infect Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
Beth-Ann G Coller, Jeffrey Blue, Rituparna Das, Sheri Dubey, Lynn Finelli, Tracy Kemp

Vaccine· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
May S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, Li Li, Trina Racine, Tracy Kemp

CMAJ· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults.
Andrew W Artenstein, Casey Johnson, Thomas C Marbury, Dennis Morrison, Paul S Blum, Tracy Kemp

Vaccine· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.
Thomas P Monath, Joseph R Caldwell, Wolfgang Mundt, Joan Fusco, Casey S Johnson, Tracy Kemp

Int J Infect Dis· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis